LIPOGEMS RAISES €12.5M ($13.2M) TO ACCELERATE THE EXPANSION IN KNEE OSTEOARTHRITIS

/PRNewswire/ -- Lipogems, a clinical stage- global medical technology company that utilizes autologous adipose tissue for therapeutic use in orthopaedics and...

Related Keywords

Italy ,Italian ,Carl Llewellyn ,Stefano Buono ,Euronext Milan Stock Exchange ,Holding Company ,Company Under Italian ,Novartis ,Knee Osteoarthritis ,Lipogems United ,Business Model ,Venture Capital ,Advanced Accelerator Applications ,Lipogems ,